<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/194266</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;194266v4</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;194266</article-id><article-id pub-id-type="other" hwp:sub-type="slug">194266</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">194266</article-id><article-id pub-id-type="other" hwp:sub-type="tag">194266</article-id><article-version>1.4</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Genetics" hwp:journal="biorxiv"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Plasma amyloid β levels are driven by genetic variants near <italic toggle="yes">APOE, BACE1, APP, PSEN2:</italic> A genome-wide association study in over 12,000 non-demented participants</article-title></title-group><author-notes hwp:id="author-notes-1"><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2 xref-fn-1-3"><label>*</label><p hwp:id="p-1">contributed equally to this work</p></fn><fn id="n2" fn-type="equal" hwp:id="fn-2" hwp:rev-id="xref-fn-2-1 xref-fn-2-2 xref-fn-2-3"><label>**</label><p hwp:id="p-2">contributed equally to this work</p></fn><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1"><label>#</label><bold>Corresponding authors’ information</bold>, Cornelia M van Duijn, Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Old Road Campus, Oxford, OX3 7LF, United Kingdom, E-mail: <email hwp:id="email-1">Cornelia.vanDuijn@ndph.ox.ac.uk</email></corresp></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-7321-8575</contrib-id><name name-style="western" hwp:sortable="Damotte Vincent"><surname>Damotte</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">*</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-7321-8575"/></contrib><contrib contrib-type="author" hwp:id="contrib-2"><name name-style="western" hwp:sortable="van der Lee Sven J"><surname>van der Lee</surname><given-names>Sven J</given-names></name><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">*</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Chouraki Vincent"><surname>Chouraki</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-3" hwp:rel-id="fn-1">*</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Grenier-Boley Benjamin"><surname>Grenier-Boley</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-3" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Simino Jeannette"><surname>Simino</surname><given-names>Jeannette</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Adams Hieab"><surname>Adams</surname><given-names>Hieab</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Tosto Giuseppe"><surname>Tosto</surname><given-names>Giuseppe</given-names></name><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="White Charles"><surname>White</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-1" hwp:rel-id="aff-9">9</xref><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-1" hwp:rel-id="aff-10">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Terzikhan Natalie"><surname>Terzikhan</surname><given-names>Natalie</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-1" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Cruchaga Carlos"><surname>Cruchaga</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-1" hwp:rel-id="aff-12">12</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Knol Maria J."><surname>Knol</surname><given-names>Maria J.</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-3" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Li Shuo"><surname>Li</surname><given-names>Shuo</given-names></name><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-1" hwp:rel-id="aff-13">13</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-1" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Schraen Susanna"><surname>Schraen</surname><given-names>Susanna</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-1" hwp:rel-id="aff-15">15</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="Grove Megan L."><surname>Grove</surname><given-names>Megan L.</given-names></name><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-1" hwp:rel-id="aff-16">16</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-1115-4430</contrib-id><name name-style="western" hwp:sortable="Satizabal Claudia"><surname>Satizabal</surname><given-names>Claudia</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-2" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-2" hwp:rel-id="aff-14">14</xref><object-id pub-id-type="other" hwp:sub-type="orcid" xlink:href="http://orcid.org/0000-0002-1115-4430"/></contrib><contrib contrib-type="author" hwp:id="contrib-16"><name name-style="western" hwp:sortable="Amin Najaf"><surname>Amin</surname><given-names>Najaf</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-4" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-17"><name name-style="western" hwp:sortable="Berr Claudine"><surname>Berr</surname><given-names>Claudine</given-names></name><xref ref-type="aff" rid="a17" hwp:id="xref-aff-17-1" hwp:rel-id="aff-17">17</xref></contrib><contrib contrib-type="author" hwp:id="contrib-18"><name name-style="western" hwp:sortable="Younkin Steven"><surname>Younkin</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="a18" hwp:id="xref-aff-18-1" hwp:rel-id="aff-18">18</xref></contrib><contrib contrib-type="author" hwp:id="contrib-19"><collab hwp:id="collab-1">Alzheimer’s Disease Neuroimaging Initiative</collab></contrib><contrib contrib-type="author" hwp:id="contrib-20"><name name-style="western" hwp:sortable="Gottesman Rebecca F."><surname>Gottesman</surname><given-names>Rebecca F.</given-names></name><xref ref-type="aff" rid="a19" hwp:id="xref-aff-19-1" hwp:rel-id="aff-19">19</xref><xref ref-type="aff" rid="a20" hwp:id="xref-aff-20-1" hwp:rel-id="aff-20">20</xref></contrib><contrib contrib-type="author" hwp:id="contrib-21"><name name-style="western" hwp:sortable="Buée Luc"><surname>Buée</surname><given-names>Luc</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-4" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-1" hwp:rel-id="aff-21">21</xref></contrib><contrib contrib-type="author" hwp:id="contrib-22"><name name-style="western" hwp:sortable="Beiser Alexa"><surname>Beiser</surname><given-names>Alexa</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-3" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-2" hwp:rel-id="aff-13">13</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-3" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-23"><name name-style="western" hwp:sortable="Knopman David S."><surname>Knopman</surname><given-names>David S.</given-names></name><xref ref-type="aff" rid="a22" hwp:id="xref-aff-22-1" hwp:rel-id="aff-22">22</xref></contrib><contrib contrib-type="author" hwp:id="contrib-24"><name name-style="western" hwp:sortable="Uitterlinden Andre"><surname>Uitterlinden</surname><given-names>Andre</given-names></name><xref ref-type="aff" rid="a23" hwp:id="xref-aff-23-1" hwp:rel-id="aff-23">23</xref></contrib><contrib contrib-type="author" hwp:id="contrib-25"><name name-style="western" hwp:sortable="DeCarli Charles"><surname>DeCarli</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-1" hwp:rel-id="aff-24">24</xref></contrib><contrib contrib-type="author" hwp:id="contrib-26"><name name-style="western" hwp:sortable="Bressler Jan"><surname>Bressler</surname><given-names>Jan</given-names></name><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-2" hwp:rel-id="aff-16">16</xref></contrib><contrib contrib-type="author" hwp:id="contrib-27"><name name-style="western" hwp:sortable="DeStefano Anita"><surname>DeStefano</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-4" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-3" hwp:rel-id="aff-13">13</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-4" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-28"><name name-style="western" hwp:sortable="Dartigues Jean-François"><surname>Dartigues</surname><given-names>Jean-François</given-names></name><xref ref-type="aff" rid="a25" hwp:id="xref-aff-25-1" hwp:rel-id="aff-25">25</xref></contrib><contrib contrib-type="author" hwp:id="contrib-29"><name name-style="western" hwp:sortable="Yang Qiong"><surname>Yang</surname><given-names>Qiong</given-names></name><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-4" hwp:rel-id="aff-13">13</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-5" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-30"><name name-style="western" hwp:sortable="Boerwinkle Eric"><surname>Boerwinkle</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-3" hwp:rel-id="aff-16">16</xref><xref ref-type="aff" rid="a26" hwp:id="xref-aff-26-1" hwp:rel-id="aff-26">26</xref></contrib><contrib contrib-type="author" hwp:id="contrib-31"><name name-style="western" hwp:sortable="Tzourio Christophe"><surname>Tzourio</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="a25" hwp:id="xref-aff-25-2" hwp:rel-id="aff-25">25</xref></contrib><contrib contrib-type="author" hwp:id="contrib-32"><name name-style="western" hwp:sortable="Fornage Myriam"><surname>Fornage</surname><given-names>Myriam</given-names></name><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-4" hwp:rel-id="aff-16">16</xref><xref ref-type="aff" rid="a27" hwp:id="xref-aff-27-1" hwp:rel-id="aff-27">27</xref></contrib><contrib contrib-type="author" hwp:id="contrib-33"><name name-style="western" hwp:sortable="Ikram M Arfan"><surname>Ikram</surname><given-names>M Arfan</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-34"><name name-style="western" hwp:sortable="Amouyel Philippe"><surname>Amouyel</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-5" hwp:rel-id="aff-1">1</xref></contrib><contrib contrib-type="author" hwp:id="contrib-35"><name name-style="western" hwp:sortable="de Jager Phil"><surname>de Jager</surname><given-names>Phil</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-2" hwp:rel-id="aff-9">9</xref><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-2" hwp:rel-id="aff-10">10</xref><xref ref-type="aff" rid="a28" hwp:id="xref-aff-28-1" hwp:rel-id="aff-28">28</xref></contrib><contrib contrib-type="author" hwp:id="contrib-36"><name name-style="western" hwp:sortable="Reitz Christiane"><surname>Reitz</surname><given-names>Christiane</given-names></name><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-2" hwp:rel-id="aff-7">7</xref><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-2" hwp:rel-id="aff-8">8</xref><xref ref-type="aff" rid="a29" hwp:id="xref-aff-29-1" hwp:rel-id="aff-29">29</xref><xref ref-type="aff" rid="a30" hwp:id="xref-aff-30-1" hwp:rel-id="aff-30">30</xref></contrib><contrib contrib-type="author" hwp:id="contrib-37"><name name-style="western" hwp:sortable="Mosley Thomas H Jr."><surname>Mosley</surname><given-names>Thomas H</given-names><suffix>Jr.</suffix></name><xref ref-type="aff" rid="a31" hwp:id="xref-aff-31-1" hwp:rel-id="aff-31">31</xref></contrib><contrib contrib-type="author" hwp:id="contrib-38"><name name-style="western" hwp:sortable="Lambert Jean-Charles"><surname>Lambert</surname><given-names>Jean-Charles</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-6" hwp:rel-id="aff-1">1</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-1" hwp:rel-id="fn-2">**</xref></contrib><contrib contrib-type="author" hwp:id="contrib-39"><name name-style="western" hwp:sortable="Seshadri Sudha"><surname>Seshadri</surname><given-names>Sudha</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-5" hwp:rel-id="aff-4">4</xref><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-6" hwp:rel-id="aff-14">14</xref><xref ref-type="aff" rid="a32" hwp:id="xref-aff-32-1" hwp:rel-id="aff-32">32</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-2" hwp:rel-id="fn-2">**</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-40"><name name-style="western" hwp:sortable="van Duijn Cornelia"><surname>van Duijn</surname><given-names>Cornelia</given-names></name><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-5" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a33" hwp:id="xref-aff-33-1" hwp:rel-id="aff-33">33</xref><xref ref-type="fn" rid="n2" hwp:id="xref-fn-2-3" hwp:rel-id="fn-2">**</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">#</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2 xref-aff-1-3 xref-aff-1-4 xref-aff-1-5 xref-aff-1-6"><label>1</label><institution hwp:id="institution-1">Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, U1167 - RID-AGE – Labex DISTALZ Risk factors and molecular determinants of aging diseases</institution>, F-59000, Lille, <country>France</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1"><label>2</label><institution hwp:id="institution-2">Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC</institution>, Amsterdam, <country>The Netherlands</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2 xref-aff-3-3 xref-aff-3-4 xref-aff-3-5"><label>3</label><institution hwp:id="institution-3">Department of Epidemiology, Erasmus Medical Center</institution>, Rotterdam, <country>The Netherlands</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1 xref-aff-4-2 xref-aff-4-3 xref-aff-4-4 xref-aff-4-5"><label>4</label><institution hwp:id="institution-4">Department of Neurology, Boston University School of Medicine</institution>, Boston, MA, <country>USA</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1"><label>5</label><institution hwp:id="institution-5">Gertrude C Ford MIND Center, Department of Data Science, John D. Bower School of Population Health, University of Mississippi Medical Center</institution>, Jackson, MS, <country>USA</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2"><label>6</label><institution hwp:id="institution-6">Departments of Epidemiology, Neurology, and Radiology and Nuclear Medicine, Erasmus Medical Center</institution>, Rotterdam, <country>the Netherlands</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1 xref-aff-7-2"><label>7</label><institution hwp:id="institution-7">Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University</institution>, New York, NY, <country>USA</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1 xref-aff-8-2"><label>8</label><institution hwp:id="institution-8">Gertrude H. Sergievsky Center, Columbia University</institution>, New York, NY, <country>USA</country></aff><aff id="a9" hwp:id="aff-9" hwp:rev-id="xref-aff-9-1 xref-aff-9-2"><label>9</label><institution hwp:id="institution-9">Program in Translational NeuroPsychiatric Genomics, Institute for the Neurosciences, Departments of Neurology and Psychiatry, Brigham and Women’s Hospital</institution>, Boston, Massachusetts, <country>United States of America</country></aff><aff id="a10" hwp:id="aff-10" hwp:rev-id="xref-aff-10-1 xref-aff-10-2"><label>10</label><institution hwp:id="institution-10">Program in Medical and Population Genetics, Broad Institute</institution>, Cambridge, Massachusetts, <country>United States of America</country></aff><aff id="a11" hwp:id="aff-11" hwp:rev-id="xref-aff-11-1"><label>11</label><institution hwp:id="institution-11">Department of Respiratory Medicine, Ghent University Hospital</institution>, Ghent, <country>Belgium</country></aff><aff id="a12" hwp:id="aff-12" hwp:rev-id="xref-aff-12-1"><label>12</label><institution hwp:id="institution-12">Department of Psychiatry, Washington University in St. Louis</institution>, Saint Louis, Missouri, <country>USA</country></aff><aff id="a13" hwp:id="aff-13" hwp:rev-id="xref-aff-13-1 xref-aff-13-2 xref-aff-13-3 xref-aff-13-4"><label>13</label><institution hwp:id="institution-13">Department of Biostatistics, Boston University School of Public Health</institution>, Boston, MA, <country>USA</country></aff><aff id="a14" hwp:id="aff-14" hwp:rev-id="xref-aff-14-1 xref-aff-14-2 xref-aff-14-3 xref-aff-14-4 xref-aff-14-5 xref-aff-14-6"><label>14</label><institution hwp:id="institution-14">The Framingham Heart Study</institution>, Framingham, MA, <country>USA</country></aff><aff id="a15" hwp:id="aff-15" hwp:rev-id="xref-aff-15-1"><label>15</label><institution hwp:id="institution-15">Université Lille, CHU-Lille, Inserm, UF de Neurobiologie, CBPG</institution>, Lille, <country>France</country></aff><aff id="a16" hwp:id="aff-16" hwp:rev-id="xref-aff-16-1 xref-aff-16-2 xref-aff-16-3 xref-aff-16-4"><label>16</label><institution hwp:id="institution-16">Human Genetics Center, Department of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, The University of Texas Health Science Center at Houston</institution>, Houston, Texas, <country>USA</country></aff><aff id="a17" hwp:id="aff-17" hwp:rev-id="xref-aff-17-1"><label>17</label><institution hwp:id="institution-17">INSERM U1061, University of Montpellier</institution>, Montpellier, <country>France</country></aff><aff id="a18" hwp:id="aff-18" hwp:rev-id="xref-aff-18-1"><label>18</label><institution hwp:id="institution-18">Department of Neuroscience, Mayo Clinic</institution>, Jacksonville, Florida 32224, <country>USA</country></aff><aff id="a19" hwp:id="aff-19" hwp:rev-id="xref-aff-19-1"><label>19</label><institution hwp:id="institution-19">Department of Neurology, Johns Hopkins University School of Medicine</institution>, Baltimore, MD <country>USA</country></aff><aff id="a20" hwp:id="aff-20" hwp:rev-id="xref-aff-20-1"><label>20</label><institution hwp:id="institution-20">Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health</institution>, Baltimore, MD, <country>USA</country></aff><aff id="a21" hwp:id="aff-21" hwp:rev-id="xref-aff-21-1"><label>21</label><institution hwp:id="institution-21">Université de Lille, Institut National de la Santé et de la Recherche Medicale (INSERM), CHU Lille, UMR-S 1172 JPArc</institution>, Lille, <country>France</country></aff><aff id="a22" hwp:id="aff-22" hwp:rev-id="xref-aff-22-1"><label>22</label><institution hwp:id="institution-22">Department of Neurology, Mayo Clinic College of Medicine</institution>, Rochester, MN, <country>USA</country></aff><aff id="a23" hwp:id="aff-23" hwp:rev-id="xref-aff-23-1"><label>23</label><institution hwp:id="institution-23">Department of Internal Medicine, Erasmus Medical Center</institution>, Rotterdam, <country>The Netherlands</country></aff><aff id="a24" hwp:id="aff-24" hwp:rev-id="xref-aff-24-1"><label>24</label><institution hwp:id="institution-24">Department of Neurology, University of California at Davis</institution>, Davis, CA, <country>USA</country></aff><aff id="a25" hwp:id="aff-25" hwp:rev-id="xref-aff-25-1 xref-aff-25-2"><label>25</label><institution hwp:id="institution-25">INSERM, UMR1219, Bordeaux University, Bordeaux Population Health Research Center</institution>, <country>France</country></aff><aff id="a26" hwp:id="aff-26" hwp:rev-id="xref-aff-26-1"><label>26</label><institution hwp:id="institution-26">Human Genome Sequencing Center, Baylor College of Medicine</institution>, Houston, Texas, <country>USA</country></aff><aff id="a27" hwp:id="aff-27" hwp:rev-id="xref-aff-27-1"><label>27</label><institution hwp:id="institution-27">Brown Foundation Institute of Molecular Medicine, McGovern Medical School, The University of Texas Health Science Center at Houston</institution>, Houston, Texas, <country>USA</country></aff><aff id="a28" hwp:id="aff-28" hwp:rev-id="xref-aff-28-1"><label>28</label><institution hwp:id="institution-28">Center for Translational &amp; Systems Neuroimmunology, Department of Neurology, Columbia University Medical Center</institution>, New York, New York, <country>United States of America</country></aff><aff id="a29" hwp:id="aff-29" hwp:rev-id="xref-aff-29-1"><label>29</label><institution hwp:id="institution-29">Department of Neurology, Columbia University</institution>, New York, NY, <country>USA</country></aff><aff id="a30" hwp:id="aff-30" hwp:rev-id="xref-aff-30-1"><label>30</label><institution hwp:id="institution-30">Department of Epidemiology, Columbia University</institution>, New York, NY, <country>USA</country></aff><aff id="a31" hwp:id="aff-31" hwp:rev-id="xref-aff-31-1"><label>31</label><institution hwp:id="institution-31">Gertrude C Ford MIND Center, Department of Medicine, University of Mississippi Medical Center</institution>, Jackson, MS, <country>USA</country></aff><aff id="a32" hwp:id="aff-32" hwp:rev-id="xref-aff-32-1"><label>32</label><institution hwp:id="institution-32">Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, UT Health San Antonio</institution>, San Antonio, Texas, <country>USA</country></aff><aff id="a33" hwp:id="aff-33" hwp:rev-id="xref-aff-33-1"><label>33</label><institution hwp:id="institution-33">Nuffield Department of Population Health, University of Oxford</institution>, Oxford, <country>UK</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2021"><year>2021</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2017-09-27T06:37:19-07:00">
    <day>27</day><month>9</month><year>2017</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2021-01-13T11:33:15-08:00">
    <day>13</day><month>1</month><year>2021</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2017-09-27T06:43:18-07:00">
    <day>27</day><month>9</month><year>2017</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2021-01-13T11:36:29-08:00">
    <day>13</day><month>1</month><year>2021</year>
  </pub-date><elocation-id>194266</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2017-09-26"><day>26</day><month>9</month><year>2017</year></date>
<date date-type="rev-recd" hwp:start="2021-01-13"><day>13</day><month>1</month><year>2021</year></date>
<date date-type="accepted" hwp:start="2021-01-13"><day>13</day><month>1</month><year>2021</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2021, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2021</copyright-year><license hwp:id="license-1"><p hwp:id="p-3">The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.</p></license></permissions><self-uri xlink:href="194266.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2021/pdf/194266v4.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="194266.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2021/abstracts/194266v4/194266v4.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2021/fulltext/194266v4/194266v4.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><sec hwp:id="sec-1"><title hwp:id="title-2">INTRODUCTION</title><p hwp:id="p-4">There is increasing interest in plasma Aβ as an endophenotype and biomarker of Alzheimer’s disease (AD). Identifying the genetic determinants of plasma Aβ levels may elucidate important processes that determine plasma Aβ measures.</p></sec><sec hwp:id="sec-2"><title hwp:id="title-3">METHODS</title><p hwp:id="p-5">We included 12,369 non-demented participants derived from eight population-based studies. Imputed genetic data and plasma Aβ1-40, Aβ1-42 levels and Aβ1-42/Aβ1-40 ratio were used to perform genome-wide association studies, gene-based and pathway analyses. Significant variants and genes were followed-up for the association with PET Aβ deposition and AD risk.</p></sec><sec hwp:id="sec-3"><title hwp:id="title-4">RESULTS</title><p hwp:id="p-6">Single-variant analysis identified associations across <italic toggle="yes">APOE</italic> for Aβ1-42 and Aβ1-42/Aβ1-40 ratio, and <italic toggle="yes">BACE1</italic> for Aβ1-40. Gene-based analysis of Aβ1-40 additionally identified associations for <italic toggle="yes">APP</italic>, <italic toggle="yes">PSEN2</italic>, <italic toggle="yes">CCK</italic> and <italic toggle="yes">ZNF397</italic>. There was suggestive interaction between a <italic toggle="yes">BACE1</italic> variant and <italic toggle="yes">APOE</italic>ε4 on brain Aβ deposition.</p></sec><sec hwp:id="sec-4"><title hwp:id="title-5">DISCUSSION</title><p hwp:id="p-7">Identification of variants near/in known major Aβ-processing genes strengthens the relevance of plasma-Aβ levels both as an endophenotype and a biomarker of AD.</p></sec></abstract><kwd-group kwd-group-type="author" hwp:id="kwd-group-1"><title hwp:id="title-6">Keywords</title><kwd hwp:id="kwd-1">Plasma amyloid β levels</kwd><kwd hwp:id="kwd-2">genetic epidemiology</kwd><kwd hwp:id="kwd-3">genome□wide association study</kwd><kwd hwp:id="kwd-4"><italic toggle="yes">APOE</italic></kwd><kwd hwp:id="kwd-5"><italic toggle="yes">BACE1</italic></kwd><kwd hwp:id="kwd-6"><italic toggle="yes">APP</italic></kwd><kwd hwp:id="kwd-7"><italic toggle="yes">PSEN2</italic></kwd><kwd hwp:id="kwd-8">Alzheimer’s disease</kwd><kwd hwp:id="kwd-9">preclinical biomarkers</kwd><kwd hwp:id="kwd-10">plasma biomarkers</kwd></kwd-group><counts><page-count count="32"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta><notes hwp:id="notes-1"><notes notes-type="competing-interest-statement" hwp:id="notes-2"><title hwp:id="title-7">Competing Interest Statement</title><p hwp:id="p-8">The authors have declared no competing interest.</p></notes></notes></front><body><sec id="s1" hwp:id="sec-5"><label>1.</label><title hwp:id="title-8">Introduction</title><p hwp:id="p-9">Aβ deposition is one of the hallmarks of Alzheimer’s disease (AD). Amyloid β (Aβ) peptides are the products of the catalytic processing of the Aβ precursor protein (APP) by the β-secretase, BACE1 and the γ-secretase complex [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>]. Aβ peptides are able to self-assemble in soluble Aβ oligomers but also in insoluble fibrils that can aggregate as plaques in the brain parenchyma or in the wall of blood vessels where they constitute defining hallmarks of Alzheimer’s disease (AD) [<xref ref-type="bibr" rid="c2" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>] and cerebral amyloid angiopathy (CAA), which is seen in many patients [<xref ref-type="bibr" rid="c3" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>]. Aβ peptides are mainly produced in the brain where <italic toggle="yes">APP</italic> and <italic toggle="yes">BACE1</italic> are both highly expressed [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>], but also in circulating blood platelets [<xref ref-type="bibr" rid="c4" hwp:id="xref-ref-4-1" hwp:rel-id="ref-4">4</xref>], in the pancreas [<xref ref-type="bibr" rid="c5" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>] and the kidney [<xref ref-type="bibr" rid="c6" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>].</p><p hwp:id="p-10">There is strong evidence pointing toward a central role of Aβ peptides in the pathophysiology of AD [<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>]. Studies have shown that a large variety of rare mutations in genes involved in Aβ production, including <italic toggle="yes">APP</italic>, <italic toggle="yes">PSEN1</italic> and <italic toggle="yes">PSEN2</italic>, lead to autosomal dominant early-onset forms of AD and to lobar hemorrhage from cerebral amyloid angiopathy [<xref ref-type="bibr" rid="c8" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>]. Moreover, apolipoprotein E (<italic toggle="yes">APOE</italic>) ε4, the major genetic risk factor for AD in the general population [<xref ref-type="bibr" rid="c9" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>], has been implicated in Aβ aggregation, deposition and clearance, both in brain and in blood vessels [<xref ref-type="bibr" rid="c7" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref>, <xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>]. Although for long the Aβ –pathway did not emerge in our genome-wide association studies (GWAS) of AD [<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>], our most recent GWAS study highlighted Aβ –processing pathway and APP catabolic process pathway in late-onset Alzheimer’s disease (LOAD) [<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>]. We and others have also explored the genetics of Aβ through genome-wide association studies (GWAS) on quantitative measures of Aβ peptides, in the cerebrospinal fluid (CSF) or brain, through Pittsburgh Compound B (PiB) positron emission tomography (PET) scan or autopsy [<xref ref-type="bibr" rid="c13" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>–<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-1" hwp:rel-id="ref-17">17</xref>]. Combining the effect of AD genetic loci in a genetic risk score shows that the combined AD genes are statistically significantly related to CSF Aβ42 [<xref ref-type="bibr" rid="c17" hwp:id="xref-ref-17-2" hwp:rel-id="ref-17">17</xref>].</p><p hwp:id="p-11">Although Aβ can be assessed in CSF and brain (PiB PET), these are of limited use for clinical and epidemiological studies in the population, either because of lower compliance (CSF) or higher costs (PiB PET). There is increasing interest in Aβ metabolism in blood. Aβ peptides produced in the brain can be degraded locally or transported into the CSF and the blood stream where they can be detected [<xref ref-type="bibr" rid="c18" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>]. Although the brain-derived Aβ peptides in the circulation cannot be distinguished from Aβ derived from blood platelets, kidney or pancreas, a recent study using immunoprecipitation coupled with mass spectrometry to measure plasma Aβ1-40/Aβ1-42 and APP/Aβ1-42 ratios was able to accurately predict individual brain amyloid-β-positive or -negative status [<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>]. Also, studies assessing Aβ1-40 and Aβ1-42 using immunoassays show that these can predict Aβ status in the brain as assessed by PiB PET [<xref ref-type="bibr" rid="c20" hwp:id="xref-ref-20-1" hwp:rel-id="ref-20">20</xref>] and that changes in the blood and plasma occur simultaneously [<xref ref-type="bibr" rid="c21" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>].</p><p hwp:id="p-12">In our studies, we have also shown that plasma Aβ concentrations are prospectively associated with the future risk of developing AD [<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>–<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>]. Despite the fact that we have used less sensitive techniques to measure plasma Aβ levels, we found modest but significant correlation with amyloid burden in the CSF and in the brain [<xref ref-type="bibr" rid="c26" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>, <xref ref-type="bibr" rid="c27" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>]. Identifying the genetic determinants of plasma Aβ levels may elucidate important processes that determine plasma Aβ measures. With this goal, we previously conducted a GWAS meta-analysis of plasma Aβ levels in 3,528 nondemented participants, but failed to find genome-wide significant associations [<xref ref-type="bibr" rid="c28" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>], indicating a lack of power. As the more sensitive measures are not yet available in large samples with genome wide-genetic data we therefore aimed to increase the studied sample size of our previous work. The present study is a GWAS meta-analysis of plasma Aβ levels in over twelve thousands individuals aiming to elucidate processes that determine plasma beta amyloid.</p></sec><sec id="s2" hwp:id="sec-6"><label>2.</label><title hwp:id="title-9">Methods</title><sec id="s2a" hwp:id="sec-7"><label>2.1.</label><title hwp:id="title-10">Study populations</title><p hwp:id="p-13">We included data from 12,369 European-descent participants from eight studies, the Framingham Heart Study (FHS; n=6,735), the Rotterdam study (RS, n=1,958), the Three City Study (3C; n=1,954), the Atherosclerosis Risk in Communities Study (ARIC; n=830), the Washington Heights-Inwood Community Aging Project (WHICAP; n=193), the Epidemiological Prevention study Zoetermeer (EPOZ; n=397), the Alzheimer’s Disease Neuroimaging Initiative (ADNI; n=173) and the Erasmus Rucphen Family Study (ERF; n=129). In each study, we excluded participants with prevalent dementia at the time of blood sampling used for plasma Aβ assessment (see Supplementary Materials and Methods 1 for a detailed description of each study).</p></sec><sec id="s2b" hwp:id="sec-8"><label>2.2.</label><title hwp:id="title-11">Plasma Aβ assessment</title><p hwp:id="p-14">Each study used different protocols for blood sampling, plasma extraction and storage and plasma Aβ assessment that have been detailed in previous publications [<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-2" hwp:rel-id="ref-22">22</xref>, <xref ref-type="bibr" rid="c23" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>, <xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-2" hwp:rel-id="ref-25">25</xref>, <xref ref-type="bibr" rid="c29" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>–<xref ref-type="bibr" rid="c31" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>]. In the FHS, Rotterdam and 3C Study, plasma Aβ levels were measured at different times because of cost considerations. Various assays were used to quantify plasma Aβ1-40 and Aβ1-42 levels (see Supplementary Materials and Methods 2 for a detailed description of the protocols used in each study and Supplementary Table 1 for baseline characteristics of the study populations).</p></sec><sec id="s2c" hwp:id="sec-9"><label>2.3.</label><title hwp:id="title-12">Genotyping</title><p hwp:id="p-15">Each study used different genotyping platforms as previously published [<xref ref-type="bibr" rid="c11" hwp:id="xref-ref-11-2" hwp:rel-id="ref-11">11</xref>]. After applying preimputation variant and sample filters, genotypes were imputed using the 1000 Genomes phase 1 version 3 (all ethnicities) imputation panel and various imputation pipelines (see Supplementary Methods 3). <italic toggle="yes">APOE</italic> genotyping was performed as part of protocols specific to each study (see Supplementary Methods 4).</p></sec><sec id="s2d" hwp:id="sec-10"><label>2.4.</label><title hwp:id="title-13">Statistical analyses</title><sec id="s2d1" hwp:id="sec-11"><label>2.4.1.</label><title hwp:id="title-14">Plasma Aβ levels</title><p hwp:id="p-16">Plasma Aβ levels were expressed as pg/mL. In each study and for each Aβ dosage, we excluded values that were over or below 4 standard deviations around the mean. To study the variations of plasma Aβ levels in a consistent way across studies, we performed a ranked-based inverse normal transformation of plasma Aβ levels in each study. If they were significantly associated with plasma Aβ levels, this transformation was performed after adjusting for batch effect and other technical artifacts.</p></sec><sec id="s2d2" hwp:id="sec-12"><label>2.4.2.</label><title hwp:id="title-15">Genome□wide association studies</title><p hwp:id="p-17">Each study performed genome□wide association studies of plasma Aβ1-40 and Aβ1-42 levels and Aβ1-42/Aβ1-40 ratio using 1000 Genomes imputed data. According to the imputation pipelines used, genetic information was available either as allele dosages or genotype probabilities. In each study, we excluded results from variants that had low imputation quality (r2 or info score &lt; 0.3), variants with low frequency (minor allele frequency &lt; 0.005 or minor allele count &lt; 7) and variants that were available in small number of participant (n &lt; 30). Association of genetic variations with plasma Aβ levels were assessed in linear regression models adjusted for sex and age at blood collection. If significantly associated with plasma Aβ levels, principal components were added in the models to account for population structure.</p></sec><sec id="s2d3" hwp:id="sec-13"><label>2.4.3.</label><title hwp:id="title-16">Genome□wide meta-analysis</title><p hwp:id="p-18">Before meta-analysis, we applied a series of filters and quality check that were previously published (see Supplementary Figures 1 and 2) [<xref ref-type="bibr" rid="c32" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>]. We performed an inverse variance weighted genome□wide meta-analysis, accounting for genomic inflation factors using the METAL software [<xref ref-type="bibr" rid="c33" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>]. Finally, we retained variants that had been meta-analyzed at least in the 3 largest available populations (FHS, RS and 3C). Statistical significance was defined as a p-value below 5×10<sup>-8</sup>. Signals with p-values between 1×10<sup>-5</sup> and 5×10<sup>-8</sup> were considered suggestive. Additional graphs and analyses were done using R v3.6.1. To confirm the <italic toggle="yes">APOE</italic> signal we obtained in our genome□wide meta-analysis, we reran our analysis using genotyped <italic toggle="yes">APOE</italic> ε4 and <italic toggle="yes">APOE</italic> ε2 status, adjusting for age and sex.</p></sec><sec id="s2d4" hwp:id="sec-14"><label>2.4.4.</label><title hwp:id="title-17">Gene-based and pathway analyses</title><p hwp:id="p-19">We tested aggregated effects of SNPs located within genes using Multi-marker Analysis of GenoMic Annotation (MAGMA) v1.07 tool [<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>]. For each dosage, a total of 18,089 genes were tested, resulting in a significance threshold of 2.76×10<sup>-6</sup>. Pathway analyses were also performed with MAGMA v1.07 [<xref ref-type="bibr" rid="c34" hwp:id="xref-ref-34-2" hwp:rel-id="ref-34">34</xref>]. The following gene sets were used: GO (biological process, cellular component and molecular function, KEGG, Biocarta and Reactome). Pathway p-values were corrected for multiple testing using the FDR method.</p></sec><sec id="s2d5" hwp:id="sec-15"><label>2.4.5.</label><title hwp:id="title-18">Association analyses with Aβ brain deposition</title><p hwp:id="p-20">We related allelic variation at the SNP of interest with a standard measure of amyloid burden in the brain on Positron Emission Tomography (PET) imaging [<xref ref-type="bibr" rid="c35" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>] in 193 Framingham Heart Study (FHS) participants [<xref ref-type="bibr" rid="c36" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>] (see Supplementary Materials and Methods 5 for a detailed description of the protocols used). As a pre-specified hypothesis, we examined this association separately for persons with at least one <italic toggle="yes">APOE</italic> ε4 allele and those without. We report the odds ratio of having a positive amyloid scan associated with having a single copy of the allele of interest, using additive genetic models adjusted for age and sex.</p></sec><sec id="s2d6" hwp:id="sec-16"><label>2.4.6.</label><title hwp:id="title-19">Association with AD</title><p hwp:id="p-21">For significant variants and genes, we checked for association with AD. Summary statistics from the most recent genetic meta-analyses of AD were used [<xref ref-type="bibr" rid="c12" hwp:id="xref-ref-12-2" hwp:rel-id="ref-12">12</xref>, <xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>].</p></sec></sec></sec><sec id="s3" hwp:id="sec-17"><label>3.</label><title hwp:id="title-20">Results</title><sec id="s3a" hwp:id="sec-18"><label>3.1.</label><title hwp:id="title-21">Genome-wide significant variants associated with plasma Aβ levels</title><p hwp:id="p-22">After meta-analysis, we identified 21 variants reaching genome-wide significance across two loci (Supplementary Figures 3 to 8).</p><p hwp:id="p-23">The first locus was located on chromosome 19, in the <italic toggle="yes">APOE</italic> gene, with significant associations with plasma Aβ1-42 levels and plasma Aβ1-42/Aβ1-40 ratio (<xref ref-type="fig" rid="fig1" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Figures 1</xref> and <xref ref-type="fig" rid="fig2" hwp:id="xref-fig-2-1" hwp:rel-id="F2">2</xref>). For both-13 – associations, the most significant variant was rs429358 with p-values of 9.01×10<sup>-13</sup> and 6.46×10<sup>-20</sup> for Aβ1-42 levels and Aβ1-42/Aβ1-40 ratio, respectively (<xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref>). The minor allele of this variant, which denotes <italic toggle="yes">APOE</italic> ε4, was associated with lower plasma Aβ1-42 levels (effect size= −0.167 standard deviations (SD); 95% confidence interval (CI)=[−0.212; −0.121]) and lower plasma Aβ1-42/Aβ1-40 ratio (effect size=-0.212 SD; 95% CI=[−0.257; −0.121]; <xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref> and Supplementary Figure 9). We confirmed these associations using the directly genotyped <italic toggle="yes">APOE</italic> ε4 status (Supplementary Figure 10).</p><fig id="fig1" position="float" orientation="portrait" fig-type="figure" hwp:id="F1" hwp:rev-id="xref-fig-1-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;194266v4/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Figure 1.</label><caption hwp:id="caption-1"><p hwp:id="p-24">Association of frequent genetic variants with plasma Aβ1-42 in the <italic toggle="yes">APOE</italic> locus.</p></caption><graphic xlink:href="194266v4_fig1" position="float" orientation="portrait" hwp:id="graphic-1"/></fig><fig id="fig2" position="float" orientation="portrait" fig-type="figure" hwp:id="F2" hwp:rev-id="xref-fig-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;194266v4/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Figure 2.</label><caption hwp:id="caption-2"><p hwp:id="p-25">Association of frequent genetic variants with plasma Aβ1-42/Aβ1-40 ratio in the <italic toggle="yes">APOE</italic> locus.</p></caption><graphic xlink:href="194266v4_fig2" position="float" orientation="portrait" hwp:id="graphic-2"/></fig><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2 xref-table-wrap-1-3"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;194266v4/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-3"><p hwp:id="p-26">Association of top variants from genome-wide significant loci with plasma Aβ levels and amyloid-related traits.</p></caption><graphic xlink:href="194266v4_tbl1" position="float" orientation="portrait" hwp:id="graphic-3"/></table-wrap><p hwp:id="p-27">The second genome□wide significant locus was an intronic variant in the <italic toggle="yes">RNF214</italic> gene. The function on <italic toggle="yes">RNF214</italic> is largely unknown. The gene is located on chromosome 11, near the <italic toggle="yes">BACE1</italic> gene. <italic toggle="yes">BACE1</italic> encodes the β-secretase and is involved in the initial, Aβ-producing step of APP processing (<xref ref-type="fig" rid="fig3" hwp:id="xref-fig-3-1" hwp:rel-id="F3">Figure 3</xref>). For the most significant variant, rs650585, the minor allele was associated with lower plasma Aβ1-40 levels (effect size=-0.073 SD; 95%CI=[−0.099; −0.047]; p-value=2.56×10<sup>-8</sup>; <xref ref-type="table" rid="tbl1" hwp:id="xref-table-wrap-1-3" hwp:rel-id="T1">Table 1</xref> and Supplementary Figure 9). This variant is in LD (R<sup>2</sup>=0.75, 1000 Genomes phase 3) with a <italic toggle="yes">BACE1</italic> synonymous variant, rs638405, which was also associated with plasma Aβ1-40 levels (effect size=-0.071 SD, p□value=1.21×10<sup>-7</sup>).</p><fig id="fig3" position="float" orientation="portrait" fig-type="figure" hwp:id="F3" hwp:rev-id="xref-fig-3-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;194266v4/FIG3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F3</object-id><object-id pub-id-type="publisher-id">fig3</object-id><label>Figure 3.</label><caption hwp:id="caption-4"><p hwp:id="p-28">Association of frequent genetic variants with plasma Aβ1-40 in the BACE1 locus.</p></caption><graphic xlink:href="194266v4_fig3" position="float" orientation="portrait" hwp:id="graphic-4"/></fig></sec><sec id="s3b" hwp:id="sec-19"><label>3.2.</label><title hwp:id="title-22">Gene and pathway-based analyses of plasma Aβ levels</title><p hwp:id="p-29">Next, we performed gene-based tests (<xref ref-type="table" rid="tbl2" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref>, Supplementary Figures 6-8). We again observed the <italic toggle="yes">APOE, RNF214</italic> and <italic toggle="yes">BACE1</italic> genes (p=3.87×10<sup>-13</sup>, p=2.33×10<sup>-7</sup> and p=3.2×10<sup>-9</sup>, respectively), for which we had identified genome-wide significant single variant associations. Next to these genes, four genes showed gene-wide significant signals (p&lt;2.76×10<sup>-6</sup>). We found that the <italic toggle="yes">APP</italic> and <italic toggle="yes">PSEN2</italic> genes were associated with plasma Aβ1-40 levels (p=1.67×10<sup>-7</sup> and p=2.63×10<sup>-6</sup>, respectively). Interestingly, at the SNP level, there were two peaks reaching suggestive evidence for association with Aβ1-40 levels in <italic toggle="yes">APP</italic> gene (Supplementary Figure 11), probably explaining its strong association at the gene level. The two other genes were <italic toggle="yes">CCK</italic>, associated with plasma Aβ1-40 levels (p=2.63×10<sup>-6</sup>), and <italic toggle="yes">ZNF397</italic> associated with plasma Aβ1-42/1-40 ratio (p=2.27×10<sup>-6</sup>). The formal pathway analyses did not yield any significant results (Supplementary Tables 2-4).</p><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;194266v4/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-5"><p hwp:id="p-30">Associations of variants aggregated according to genes with plasma Aβ levels.</p></caption><graphic xlink:href="194266v4_tbl2" position="float" orientation="portrait" hwp:id="graphic-5"/></table-wrap></sec><sec id="s3c" hwp:id="sec-20"><label>3.3.</label><title hwp:id="title-23">Association of the BACE1 locus with PET Aβ deposition</title><p hwp:id="p-31">We tested the association of the top hit rs650585 from the BACE1 locus (see above) with Aβ deposition in the brain from subsets of the FHS population. We found an association of rs650585 with an increase of deposition in FHS-Gen3 only among <italic toggle="yes">APOE</italic>ε4 positive individuals (p = 0.02) (Supplementary Table 5).</p></sec><sec id="s3d" hwp:id="sec-21"><label>3.4.</label><title hwp:id="title-24">Variants associated with plasma amyloid associate with the risk of AD</title><p hwp:id="p-32">The <italic toggle="yes">APOE</italic> □4 allele is known to be associated with a higher risk of AD [<xref ref-type="bibr" rid="c38" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>]. We did not find significant evidence for association between genotyped <italic toggle="yes">APOE</italic> ε2 and circulating Aβ peptides levels, despite the protective effect of this variant on the risk of AD (Supplementary Figure 10).</p><p hwp:id="p-33">A significant association of <italic toggle="yes">APP</italic> gene with AD (p=8.42×10<sup>-7</sup>) was reported [<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-2" hwp:rel-id="ref-37">37</xref>]. Interestingly, one of the two peaks in <italic toggle="yes">APP</italic> reported as suggestively associated with Aβ1-40 levels (Supplementary Figure 11) was also associated with AD, whereas the second peak was not (Supplementary Figure 12) [<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-3" hwp:rel-id="ref-37">37</xref>]. Nominal significant associations of <italic toggle="yes">RNF214</italic> (p=4.8×10<sup>-5</sup>) and <italic toggle="yes">BACE1</italic> (p=1.1×10<sup>-3</sup>) with AD were reported while <italic toggle="yes">PSEN2</italic> was close to nominal association (p=5.1×10<sup>-2</sup>) [<xref ref-type="bibr" rid="c37" hwp:id="xref-ref-37-4" hwp:rel-id="ref-37">37</xref>].</p></sec></sec><sec id="s4" hwp:id="sec-22"><label>4.</label><title hwp:id="title-25">Discussion</title><p hwp:id="p-34">Plasma Aβ1-40 and Aβ1-42 levels are increasingly of interest as biomarkers for AD. To uncover the important molecular processes underlying plasma Aβ we performed GWAS of plasma Aβ measured in 12,369 non□demented subjects. Despite that we did not use the recently developed specific immune-assays we uncovered that plasma Aβ is influenced by variants in and near <italic toggle="yes">APOE</italic>, <italic toggle="yes">BACE1</italic>, <italic toggle="yes">PSEN2</italic> and <italic toggle="yes">APP</italic>. These four genes code for known key proteins involved in Aβ processing. We also identified additional signals for the genes <italic toggle="yes">CCK</italic> and <italic toggle="yes">ZNF397</italic>. The variant near <italic toggle="yes">BACE1</italic> seemed also to be associated with Aβ in the brain as measured by PET imaging and were also associated with the risk of AD. In summary, plasma Aβ can be used to disentangle its molecular background.</p><p hwp:id="p-35">The <italic toggle="yes">BACE1</italic> region encompasses several genes (<italic toggle="yes">PCSK7</italic>, <italic toggle="yes">RNF214</italic>, <italic toggle="yes">BACE1</italic>, <italic toggle="yes">CEP164</italic>) and a <italic toggle="yes">BACE1</italic> anti-sense long non-coding RNA (<italic toggle="yes">BACE1</italic>-<italic toggle="yes">AS</italic>). Although the top variant in the GWAS is located in an intron of <italic toggle="yes">RNF214</italic>, the gene-based analyses shows a significant association to <italic toggle="yes">BACE1</italic> that is more significant than the gene based test of RNF214. Since the β-secretase activity of BACE1 is necessary for Aβ peptide production, it is likely that <italic toggle="yes">BACE1</italic> or a local regulation of <italic toggle="yes">BACE1</italic> expression are responsible for this signal. We also found gene-wide significant associations with plasma Aβ1-40 levels in <italic toggle="yes">APP</italic> and <italic toggle="yes">PSEN2</italic>, two major actors of the Aβ metabolism. APP is obviously a central element of its own metabolism and PSEN2 is a key component of the γ-secretase which processes the APP C99 fragment into Aβ peptides [<xref ref-type="bibr" rid="c1" hwp:id="xref-ref-1-3" hwp:rel-id="ref-1">1</xref>]. The top variants at the <italic toggle="yes">PSEN2</italic> and <italic toggle="yes">BACE1</italic> loci were also nominally associated with Aβ1-42 levels in the same direction as Aβ1-40 levels, which is in agreement with knowledge that PSEN2 and BACE1 activities indifferently produce Aβ40 and Aβ42 peptides. Conversely, the <italic toggle="yes">APOE</italic>ε4 allele had the strongest association with Aβ1-42 levels but was not even nominally associated with Aβ1-40. This suggests that the APOE □4 isoform is not involved in the early process of Aβ peptide production but in more downstream events, such as Aβ aggregation or clearance. These results might also illustrate the greater ability to aggregate of Aβ1-42 peptides compared to Aβ1-40, and the influence of APOE isoforms in the regulation of this process [<xref ref-type="bibr" rid="c10" hwp:id="xref-ref-10-2" hwp:rel-id="ref-10">10</xref>]. Interestingly, associations of <italic toggle="yes">APOE</italic> ε2 with plasma Aβ levels were not significant and effect sizes were very small. Contrary to <italic toggle="yes">APOE</italic> ε4, the effect of <italic toggle="yes">APOE</italic> ε2 on amyloid markers has been much less studied and seems to be focused on specific brain regions, which could explain why we could not detect any association [<xref ref-type="bibr" rid="c39" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>]. This could also suggest that other, Aβ□independent, mechanisms are involved in the lower risk of AD observed in <italic toggle="yes">APOE</italic> ε2 carriers [<xref ref-type="bibr" rid="c40" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>].</p><p hwp:id="p-36">The <italic toggle="yes">CCK</italic> gene is located in a region that was reported in a GWAS on neurofibrillary tangle [<xref ref-type="bibr" rid="c16" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>]. Cholecystokinin (CCK) is a neuropeptide and gut hormone that regulates pancreatic enzyme secretion and gastrointestinal motility, and acts as a satiety signal. It is released simultaneously from intestinal cells and neurons in response to a meal. A sulfated form of cholecystokinin-8 may modulate neuronal activity in the brain [<xref ref-type="bibr" rid="c41" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref>]. The protein is located in axons, dendrites and the neuronal cell body and is involved in gastrin signaling and insulin secretion but also in neuron migration.</p><p hwp:id="p-37"><italic toggle="yes">ZNF397</italic> gene encodes a protein with a N-terminal SCAN domain, and the longer isoform contains nine C2H2-type zinc finger repeats in the C-terminal domain. The protein localizes to centromeres during interphase and early prophase, and different isoforms can repress or activate transcription in transfection studies. Interestingly, the SNP rs509477, suggestively associated with CSF Aβ1-42 in a small association study [<xref ref-type="bibr" rid="c42" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref>], is located in an enhancer of <italic toggle="yes">ZNF397</italic> (Genecards: GH18J034976), acting in hippocampus middle, anterior caudate and cingulate gyrus brain regions [<xref ref-type="bibr" rid="c43" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>]. However, this SNP was not associated with any of Aβ levels or ratio in our study.</p><p hwp:id="p-38">Our analysis shows associations of plasma Aβ levels mainly with genes that are known for long to be involved in AD (<italic toggle="yes">APOE</italic>, <italic toggle="yes">APP</italic>, <italic toggle="yes">PSEN2</italic>), are nominally associated to AD or are expressed in brain regions. Although we cannot prove the origin, this suggests that Aβ peptides measured in the blood circulation probably originate from the brain rather than from the pancreas or the kidney. This perfectly fits with recent observations showing correlation of Aβ levels in blood with its levels in CSF as well as with its deposition in brain as assessed by PET imaging [<xref ref-type="bibr" rid="c19" hwp:id="xref-ref-19-2" hwp:rel-id="ref-19">19</xref>, <xref ref-type="bibr" rid="c44" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref>].</p><p hwp:id="p-39">For long, plasma Aβ is usually considered as a poor biomarker of AD in the literature. A previous meta-analysis reported that plasma Aβ levels were not useful to make a clinical diagnosis of AD [<xref ref-type="bibr" rid="c45" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref>]. Many of the cohorts participating in the present study have previously reported that low plasma Aβ42 and Aβ42/40 ratio levels were associated with development of AD after several years of follow-up [<xref ref-type="bibr" rid="c22" hwp:id="xref-ref-22-3" hwp:rel-id="ref-22">22</xref>–<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-3" hwp:rel-id="ref-25">25</xref>]. The results of the present study are consistent with the hypothesis that Aβ in blood is predictive of AD pathophysiology and this view is strengthened by our present observation that <italic toggle="yes">APOE</italic> ε4, is both associated with low plasma Aβ42 and Aβ42/40 ratio and high AD risk. Some of those studies have also reported that this association remained significant after adjusting for <italic toggle="yes">APOE</italic> ε4 [<xref ref-type="bibr" rid="c25" hwp:id="xref-ref-25-4" hwp:rel-id="ref-25">25</xref>], suggesting that variations of plasma Aβ levels are not only an endophenotype of Aβ, but are also involved in AD pathophysiology. As such, plasma Aβ levels would not be only useful as a biomarker of an active amyloid metabolism in the brain but could also be considered as a biomarker for preventive interventions. In this light there are intriguing reports that hemodialysis or peritoneal dialysis are able to lower Aβ in the brain [<xref ref-type="bibr" rid="c46" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref>, <xref ref-type="bibr" rid="c47" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref>]. Further, the association we observed between variants near <italic toggle="yes">BACE1</italic> and plasma Aβ40 is also of interest in the light of the ongoing trials testing BACE inhibitors, even though the lack of association of these variants with AD risk should be further investigated [<xref ref-type="bibr" rid="c48" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref>].</p><p hwp:id="p-40">Our study has several strengths. First, it is, to date, the largest study of circulating amyloid peptides. This enabled us to identify factors of Aβ metabolism and we are optimistic about the relevance of the genetic signals that suggest blood levels of Aβ may have a clinical utility. Second, this study was conducted in non-demented participants and therefore is relevant for the study of early amyloid pathophysiological processes. Third, we carefully normalized the plasma Aβ data before running GWAS, thus taking into account some of the heterogeneity that has been described when using plasma Aβ levels.</p><p hwp:id="p-41">Our study has also limitations. The state of current knowledge makes it difficult to extrapolate the role of these actors from the plasma compartments to the brain and further research in this area is needed. Second, the assays used in this study non-selectively measured Aβ concentrations and could not distinguish monomers from oligomers of Aβ, whether free or protein-bound. Therefore, our interpretation of the present results might differ from other studies in which assays used selectively measured monomers or oligomers of Aβ [<xref ref-type="bibr" rid="c49" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref>]. Future studies should carefully choose assays that allow measurements of each form of Aβ as this will facilitate interpretation with regard to the balance between Aβ production, aggregation and clearance.</p><p hwp:id="p-42">In summary, our results indicate that genetic determinants of plasma Aβ40 and Aβ42 levels are close to genes known to be central actors in APP metabolism in AD. Increasing the statistical power of plasma Aβ analyses may potentially lead to the identification of currently unknown players in Aβ metabolism, novel hypotheses and hopefully, new preventive or therapeutic targets against Alzheimer’s disease.</p></sec><sec sec-type="supplementary-material" hwp:id="sec-23"><title hwp:id="title-26">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Supplementary Materials and Methods</label><media xlink:href="supplements/194266_file03.docx" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC2"><object-id pub-id-type="other" hwp:sub-type="slug">DC2</object-id><label>Supplementary Figures</label><media xlink:href="supplements/194266_file04.docx" position="float" orientation="portrait" hwp:id="media-2"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC3"><object-id pub-id-type="other" hwp:sub-type="slug">DC3</object-id><label>Supplementary Tables Part1</label><media xlink:href="supplements/194266_file05.docx" position="float" orientation="portrait" hwp:id="media-3"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC4"><object-id pub-id-type="other" hwp:sub-type="slug">DC4</object-id><label>Supplementary Tables Part2</label><media xlink:href="supplements/194266_file06.xlsx" position="float" orientation="portrait" hwp:id="media-4"/></supplementary-material></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-27">Acknowledgments/Conflicts/Funding Sources</title></ack><sec hwp:id="sec-24"><title hwp:id="title-28">Framingham Heart Study</title><p hwp:id="p-43">This work was supported by the National Heart, Lung and Blood Institute’s Framingham Heart Study (contracts N01-HC-25195 and HHSN268201500001I). This study was also supported by grants from the National Institute on Aging: AG054076, U01-AG049505, and AG008122 (S. Seshadri). S.Seshadri, A.Beiser and Q.Yang were also supported by additional grants from the National Institute on Aging (R01AG049607, AG033193, AG033040) and the National Institute of Neurological Disorders and Stroke (R01-NS017950, R01-NS087541). The SHARe (SNP Health Association Resource) project was funded by the National Heart, Lung, and Blood Institute. The Linux Cluster for Genetic Analysis (LinGA-II) on which part of the FHS computations were performed was funded by the Robert Dawson Evans Endowment of the Department of Medicine at Boston University School of Medicine and Boston Medical Center.</p></sec><sec hwp:id="sec-25"><title hwp:id="title-29">Rotterdam Study</title><p hwp:id="p-44">The Rotterdam Study is funded by Erasmus Medical Center and Erasmus University, Rotterdam, Netherlands Organization for the Health Research and Development (ZonMw), the Research Institute for Diseases in the Elderly (RIDE), the Ministry of Education, Culture and Science, the Ministry for Health, Welfare and Sports, the European Commission (DG XII), and the Municipality of Rotterdam. The authors are grateful to the study participants, the staff from the Rotterdam Study and the participating general practitioners and pharmacists. The generation and management of the Illumina exome chip v1.0 array data for the Rotterdam Study (RS-I) was executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.glimdna.org" ext-link-type="uri" xlink:href="http://www.glimdna.org" hwp:id="ext-link-1">www.glimdna.org</ext-link>), Erasmus MC, Rotterdam, The Netherlands. The generation and management of GWAS genotype data for the Rotterdam Study (RS-I, RS-II, RS-III) was executed by the Human Genotyping Facility of the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands. The GWAS datasets are supported by the Netherlands Organization of Scientific Research NWO Investments (nr. 175.010.2005.011, 911-03-012), the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, the Research Institute for Diseases in the Elderly (014-93-015; RIDE2), the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO) Netherlands Consortium for Healthy Aging (NCHA), project nr. 050-060-810. Carolina Medina-Gomez, PhD, Lennard Karsten, PhD, and Linda Broer, PhD, for QC and variant calling; Arp, Mila Jhamai, Marijn Verkerk, Lizbeth Herrera and Marjolein Peters, PhD, and Carolina Medina-Gomez, PhD, for their help in creating the GWAS database. The work for this manuscript was further supported by ADAPTED: Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development (number 115975); the CoSTREAM project (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.costream.eu" ext-link-type="uri" xlink:href="http://www.costream.eu" hwp:id="ext-link-2">www.costream.eu</ext-link>) and funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667375.</p></sec><sec hwp:id="sec-26"><title hwp:id="title-30">Three City Study</title><p hwp:id="p-45">This work was supported by INSERM, the National Foundation for Alzheimer’s disease and related disorders, the Institut Pasteur de Lille and the Centre National de Génotypage. This work has been developed and supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to Alzheimer’s disease) including funding from MEL (Metropoleeuropéenne de Lille), ERDF (European Regional Development Fund), Conseil Régional Nord Pas de Calais and the JPND-funded PERADES project. The Three-City Study was performed as part of collaboration between the Institut National de la Santé et de la Recherche Médicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthélabo. The Fondation pour la Recherche Médicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salariés, Direction Générale de la Santé, MGEN, Institut de la Longévité, Agence Française de Sécurité Sanitaire des Produits de Santé, the Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche, ANR supported the COGINUT and COVADIS projects. Fondation de France and the joint French Ministry of Research/INSERM “Cohortes et collections de données biologiques” programme. Lille Génopôle received an unconditional grant from Eisai. The Three-city biological bank was developed and maintained by the laboratory for genomic analysis LAG-BRC - Institut Pasteur de Lille. The work for this manuscript was further supported by the CoSTREAM project (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.costream.eu" ext-link-type="uri" xlink:href="http://www.costream.eu" hwp:id="ext-link-3">www.costream.eu</ext-link>) and funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667375.</p></sec><sec hwp:id="sec-27"><title hwp:id="title-31">Atherosclerosis Risk in Communities Study</title><p hwp:id="p-46">The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. Neurocognitive data was collected by U01 HL096812, HL096814, HL096899, HL096902, and HL096917 from the NIH (NHLBI, NINDS, NIA and NIDCD), with previous brain MRI examinations funded by R01HL70825 from the NHLBI. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The authors thank the staff and participants of the ARIC study for their important contributions.</p></sec><sec hwp:id="sec-28"><title hwp:id="title-32">Epidemiological Prevention study Zoetermeer</title><p hwp:id="p-47">This research was made possible by financial support from the Netherlands Organization for Scientific Research and the Health Research Development Council.</p></sec><sec hwp:id="sec-29"><title hwp:id="title-33">Washington Heights-Inwood Community Aging Project</title><p hwp:id="p-48">Data collection and sharing for this project was supported by the Washington Heights-Inwood Columbia Aging Project (WHICAP, PO1AG007232, R01AG037212, RF1AG054023) funded by the National Institute on Aging (NIA) and by the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant Number UL1TR001873. This work was also supported by National Institutes of Health grants AG042483, AG034189, and AG045334. This manuscript has been reviewed by WHICAP investigators for scientific content and consistency of data interpretation with previous WHICAP Study publications. We acknowledge the WHICAP study participants and the WHICAP research and support staff for their contributions to this study. The Columbia University Institutional Review Board reviewed and approved this project. All individuals provided written informed consent.</p></sec><sec hwp:id="sec-30"><title hwp:id="title-34">Alzheimer’s Disease Neuroimaging Initiative</title><p hwp:id="p-49">Data collection and sharing for this project was funded by the Alzheimer’s Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer’s Association; Alzheimer’s Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Cogstate; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research &amp; Development, LLC.; Johnson &amp; Johnson Pharmaceutical Research &amp; Development LLC.; Lumosity; Lundbeck; Merck &amp; Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.fnih.org" ext-link-type="uri" xlink:href="http://www.fnih.org" hwp:id="ext-link-4">www.fnih.org</ext-link>). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer’s Therapeutic Research Institute at the University of Southern California. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.</p></sec><sec hwp:id="sec-31"><title hwp:id="title-35">Eramus Rucphen Family Study</title><p hwp:id="p-50">The Erasmus Rucphen Family (ERF) has received funding from the Centre for Medical Systems Biology (CMSB) and Netherlands Consortium for Systems Biology (NCSB), both within the framework of the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). ERF study is also a part of EUROSPAN (European Special Populations Research Network) (FP6 STRP grant number 018947 (LSHG-CT-2006-01947)); European Network of Genomic and Genetic Epidemiology (ENGAGE) from the European Community’s Seventh Framework Programme (FP7/2007-2013)/grant agreement HEALTH-F4-2007-201413; “Quality of Life and Management of the Living Resources” of 5th Framework Programme (no. QLG2-CT-2002-01254); FP7 project EUROHEADPAIN (nr 602633), the Internationale Stichting Alzheimer Onderzoek (ISAO); the Hersenstichting Nederland (HSN); and the JNPD under the project PERADES (grant number 733051021, Defining Genetic, Polygenic and Environmental Risk for Alzheimer’s Disease using multiple powerful cohorts, focused Epigenetics and Stem cell metabolomics). This work in the ERF study was conducted under the grants: ADAPTED: Alzheimer’s Disease Apolipoprotein Pathology for Treatment Elucidation and Development (number 115975); the CoSTREAM project (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.costream.eu" ext-link-type="uri" xlink:href="http://www.costream.eu" hwp:id="ext-link-5">www.costream.eu</ext-link>) and has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 667375. We are grateful to all study participants and their relatives, general practitioners and neurologists for their contributions and to P. Veraart for her help in genealogy, J. Vergeer for the supervision of the laboratory work, and P. Snijders M.D. for his help in data collection.</p><p hwp:id="p-51">The authors have no conflicts of interest to disclose.</p></sec><ref-list hwp:id="ref-list-1"><title hwp:id="title-36">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2 xref-ref-1-3"><label>[1]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><string-name name-style="western" hwp:sortable="Haass C"><surname>Haass</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kaether C"><surname>Kaether</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thinakaran G"><surname>Thinakaran</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sisodia S"><surname>Sisodia</surname> <given-names>S</given-names></string-name>. <article-title hwp:id="article-title-2">Trafficking and proteolytic processing of APP</article-title>. <source hwp:id="source-1">Cold Spring Harbor perspectives in medicine</source>. <year>2012</year>;<volume>2</volume>:<fpage>a006270</fpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>[2]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Hyman BT"><surname>Hyman</surname> <given-names>BT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Phelps CH"><surname>Phelps</surname> <given-names>CH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Beach TG"><surname>Beach</surname> <given-names>TG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bigio EH"><surname>Bigio</surname> <given-names>EH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cairns NJ"><surname>Cairns</surname> <given-names>NJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carrillo MC"><surname>Carrillo</surname> <given-names>MC</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-3">National Institute on Aging-Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease</article-title>. <source hwp:id="source-2">Alzheimer’s &amp; dementia: the journal of the Alzheimer’s Association</source>. <year>2012</year>;<volume>8</volume>:<fpage>1</fpage>–<lpage>13</lpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1"><label>[3]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Viswanathan A"><surname>Viswanathan</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Greenberg SM"><surname>Greenberg</surname> <given-names>SM</given-names></string-name>. <article-title hwp:id="article-title-4">Cerebral amyloid angiopathy in the elderly</article-title>. <source hwp:id="source-3">Annals of neurology</source>. <year>2011</year>;<volume>70</volume>:<fpage>871</fpage>–<lpage>80</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4" hwp:rev-id="xref-ref-4-1"><label>[4]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Chen M"><surname>Chen</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Inestrosa NC"><surname>Inestrosa</surname> <given-names>NC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ross GS"><surname>Ross</surname> <given-names>GS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fernandez HL"><surname>Fernandez</surname> <given-names>HL</given-names></string-name>. <article-title hwp:id="article-title-5">Platelets are the primary source of amyloid beta-peptide in human blood</article-title>. <source hwp:id="source-4">Biochemical and biophysical research communications</source>. <year>1995</year>;<volume>213</volume>:<fpage>96</fpage>–<lpage>103</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1"><label>[5]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Kulas JA"><surname>Kulas</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Puig KL"><surname>Puig</surname> <given-names>KL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Combs CK"><surname>Combs</surname> <given-names>CK</given-names></string-name>. <article-title hwp:id="article-title-6">Amyloid precursor protein in pancreatic islets</article-title>. <source hwp:id="source-5">The Journal of endocrinology</source>. <year>2017</year>;<volume>235</volume>:<fpage>49</fpage>–<lpage>67</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1"><label>[6]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Selkoe DJ"><surname>Selkoe</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Podlisny MB"><surname>Podlisny</surname> <given-names>MB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Joachim CL"><surname>Joachim</surname> <given-names>CL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vickers EA"><surname>Vickers</surname> <given-names>EA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee G"><surname>Lee</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fritz LC"><surname>Fritz</surname> <given-names>LC</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-7">Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues</article-title>. <source hwp:id="source-6">Proceedings of the National Academy of Sciences of the United States of America</source>. <year>1988</year>;<volume>85</volume>:<fpage>7341</fpage>–<lpage>5</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><label>[7]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Long JM"><surname>Long</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Holtzman DM"><surname>Holtzman</surname> <given-names>DM</given-names></string-name>. <article-title hwp:id="article-title-8">Alzheimer Disease: An Update on Pathobiology and Treatment Strategies</article-title>. <source hwp:id="source-7">Cell</source>. <year>2019</year>;<volume>179</volume>:<fpage>312</fpage>–<lpage>39</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1"><label>[8]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Cacace R"><surname>Cacace</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sleegers K"><surname>Sleegers</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Van Broeckhoven C"><surname>Van Broeckhoven</surname> <given-names>C</given-names></string-name>. <article-title hwp:id="article-title-9">Molecular genetics of early-onset Alzheimer’s disease revisited</article-title>. <source hwp:id="source-8">Alzheimer’s &amp; dementia: the journal of the Alzheimer’s Association</source>. <year>2016</year>;<volume>12</volume>:<fpage>733</fpage>–<lpage>48</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1"><label>[9]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Genin E"><surname>Genin</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hannequin D"><surname>Hannequin</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wallon D"><surname>Wallon</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sleegers K"><surname>Sleegers</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hiltunen M"><surname>Hiltunen</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Combarros O"><surname>Combarros</surname> <given-names>O</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-10">APOE and Alzheimer disease: a major gene with semi-dominant inheritance</article-title>. <source hwp:id="source-9">Molecular psychiatry</source>. <year>2011</year>;<volume>16</volume>:<fpage>903</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1 xref-ref-10-2"><label>[10]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Kanekiyo T"><surname>Kanekiyo</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xu H"><surname>Xu</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bu G"><surname>Bu</surname> <given-names>G</given-names></string-name>. <article-title hwp:id="article-title-11">ApoE and Abeta in Alzheimer’s disease: accidental encounters or partners?</article-title> <source hwp:id="source-10">Neuron</source>. <year>2014</year>;<volume>81</volume>:<fpage>740</fpage>–<lpage>54</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1 xref-ref-11-2"><label>[11]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Lambert JC"><surname>Lambert</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ibrahim-Verbaas CA"><surname>Ibrahim-Verbaas</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harold D"><surname>Harold</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Naj AC"><surname>Naj</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sims R"><surname>Sims</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bellenguez C"><surname>Bellenguez</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-12">Metaanalysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease</article-title>. <source hwp:id="source-11">Nature genetics</source>. <year>2013</year>;<volume>45</volume>:<fpage>1452</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1 xref-ref-12-2"><label>[12]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><string-name name-style="western" hwp:sortable="Kunkle BW"><surname>Kunkle</surname> <given-names>BW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Grenier-Boley B"><surname>Grenier-Boley</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sims R"><surname>Sims</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bis JC"><surname>Bis</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Damotte V"><surname>Damotte</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Naj AC"><surname>Naj</surname> <given-names>AC</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-13">Genetic metaanalysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Abeta, tau, immunity and lipid processing</article-title>. <source hwp:id="source-12">Nature genetics</source>. <year>2019</year>;<volume>51</volume>:<fpage>414</fpage>–<lpage>30</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1"><label>[13]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><string-name name-style="western" hwp:sortable="Cruchaga C"><surname>Cruchaga</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kauwe JS"><surname>Kauwe</surname> <given-names>JS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harari O"><surname>Harari</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jin SC"><surname>Jin</surname> <given-names>SC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cai Y"><surname>Cai</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karch CM"><surname>Karch</surname> <given-names>CM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-14">GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer’s disease</article-title>. <source hwp:id="source-13">Neuron</source>. <year>2013</year>;<volume>78</volume>:<fpage>256</fpage>–<lpage>68</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14"><label>[14]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Ramanan VK"><surname>Ramanan</surname> <given-names>VK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Risacher SL"><surname>Risacher</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nho K"><surname>Nho</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kim S"><surname>Kim</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Swaminathan S"><surname>Swaminathan</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shen L"><surname>Shen</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-15">APOE and BCHE as modulators of cerebral amyloid deposition: a florbetapir PET genome-wide association study</article-title>. <source hwp:id="source-14">Molecular psychiatry</source>. <year>2014</year>;<volume>19</volume>:<fpage>351</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15"><label>[15]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Shulman JM"><surname>Shulman</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen K"><surname>Chen</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Keenan BT"><surname>Keenan</surname> <given-names>BT</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chibnik LB"><surname>Chibnik</surname> <given-names>LB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fleisher A"><surname>Fleisher</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thiyyagura P"><surname>Thiyyagura</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-16">Genetic susceptibility for Alzheimer disease neuritic plaque pathology</article-title>. <source hwp:id="source-15">JAMA neurology</source>. <year>2013</year>;<volume>70</volume>:<fpage>1150</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1"><label>[16]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Beecham GW"><surname>Beecham</surname> <given-names>GW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hamilton K"><surname>Hamilton</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Naj AC"><surname>Naj</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martin ER"><surname>Martin</surname> <given-names>ER</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huentelman M"><surname>Huentelman</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Myers AJ"><surname>Myers</surname> <given-names>AJ</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-17">Genomewide association meta-analysis of neuropathologic features of Alzheimer’s disease and related dementias</article-title>. <source hwp:id="source-16">PLoS genetics</source>. <year>2014</year>;<volume>10</volume>:<fpage>e1004606</fpage>.</citation></ref><ref id="c17" hwp:id="ref-17" hwp:rev-id="xref-ref-17-1 xref-ref-17-2"><label>[17]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Deming Y"><surname>Deming</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li Z"><surname>Li</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kapoor M"><surname>Kapoor</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harari O"><surname>Harari</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Del-Aguila JL"><surname>Del-Aguila</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Black K"><surname>Black</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-18">Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers</article-title>. <source hwp:id="source-17">Acta neuropathologica</source>. <year>2017</year>;<volume>133</volume>:<fpage>839</fpage>–<lpage>56</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>[18]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.18" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-18"><string-name name-style="western" hwp:sortable="Sagare AP"><surname>Sagare</surname> <given-names>AP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bell RD"><surname>Bell</surname> <given-names>RD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zlokovic BV"><surname>Zlokovic</surname> <given-names>BV</given-names></string-name>. <article-title hwp:id="article-title-19">Neurovascular defects and faulty amyloid-beta vascular clearance in Alzheimer’s disease</article-title>. <source hwp:id="source-18">Journal of Alzheimer’s disease: JAD</source>. <year>2013</year>;<volume>33</volume> Suppl <issue>1</issue>:<fpage>S87</fpage>–<lpage>100</lpage>.</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1 xref-ref-19-2"><label>[19]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Nakamura A"><surname>Nakamura</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kaneko N"><surname>Kaneko</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Villemagne VL"><surname>Villemagne</surname> <given-names>VL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kato T"><surname>Kato</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Doecke J"><surname>Doecke</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dore V"><surname>Dore</surname> <given-names>V</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-20">High performance plasma amyloid-beta biomarkers for Alzheimer’s disease</article-title>. <source hwp:id="source-19">Nature</source>. <year>2018</year>;<volume>554</volume>:<fpage>249</fpage>–<lpage>54</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20" hwp:rev-id="xref-ref-20-1"><label>[20]</label><citation publication-type="other" citation-type="journal" ref:id="194266v4.20" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Palmqvist S"><surname>Palmqvist</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Janelidze S"><surname>Janelidze</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stomrud E"><surname>Stomrud</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zetterberg H"><surname>Zetterberg</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karl J"><surname>Karl</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zink K"><surname>Zink</surname> <given-names>K</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-21">Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related betaAmyloid Status</article-title>. <source hwp:id="source-20">JAMA neurology</source>. <year>2019</year>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1"><label>[21]</label><citation publication-type="other" citation-type="journal" ref:id="194266v4.21" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Palmqvist S"><surname>Palmqvist</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Insel PS"><surname>Insel</surname> <given-names>PS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stomrud E"><surname>Stomrud</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Janelidze S"><surname>Janelidze</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zetterberg H"><surname>Zetterberg</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brix B"><surname>Brix</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-22">Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer’s disease</article-title>. <source hwp:id="source-21">EMBO molecular medicine</source>. <year>2019</year>:<fpage>e11170</fpage>.</citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1 xref-ref-22-2 xref-ref-22-3"><label>[22]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="van Oijen M"><surname>van Oijen</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hofman A"><surname>Hofman</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Soares HD"><surname>Soares</surname> <given-names>HD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Koudstaal PJ"><surname>Koudstaal</surname> <given-names>PJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Breteler MM"><surname>Breteler</surname> <given-names>MM</given-names></string-name>. <article-title hwp:id="article-title-23">Plasma Abeta(1-40) and Abeta(1-42) and the risk of dementia: a prospective case-cohort study</article-title>. <source hwp:id="source-22">The Lancet Neurology</source>. <year>2006</year>;<volume>5</volume>:<fpage>655</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1"><label>[23]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Lambert JC"><surname>Lambert</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schraen-Maschke S"><surname>Schraen-Maschke</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Richard F"><surname>Richard</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Fievet N"><surname>Fievet</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rouaud O"><surname>Rouaud</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berr C"><surname>Berr</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-24">Association of plasma amyloid beta with risk of dementia: the prospective Three-City Study</article-title>. <source hwp:id="source-23">Neurology</source>. <year>2009</year>;<volume>73</volume>:<fpage>847</fpage>–<lpage>53</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24"><label>[24]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Shah NS"><surname>Shah</surname> <given-names>NS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vidal JS"><surname>Vidal</surname> <given-names>JS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Masaki K"><surname>Masaki</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Petrovitch H"><surname>Petrovitch</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ross GW"><surname>Ross</surname> <given-names>GW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tilley C"><surname>Tilley</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-25">Midlife blood pressure, plasma beta-amyloid, and the risk for Alzheimer disease: the Honolulu Asia Aging Study</article-title>. <source hwp:id="source-24">Hypertension</source>. <year>2012</year>;<volume>59</volume>:<fpage>780</fpage>–<lpage>6</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1 xref-ref-25-2 xref-ref-25-3 xref-ref-25-4"><label>[25]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Chouraki V"><surname>Chouraki</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Beiser A"><surname>Beiser</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Younkin L"><surname>Younkin</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Preis SR"><surname>Preis</surname> <given-names>SR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weinstein G"><surname>Weinstein</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hansson O"><surname>Hansson</surname> <given-names>O</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-26">Plasma amyloid-beta and risk of Alzheimer’s disease in the Framingham Heart Study</article-title>. <source hwp:id="source-25">Alzheimer’s &amp; dementia: the journal of the Alzheimer’s Association</source>. <year>2015</year>;<volume>11</volume>:<fpage>249</fpage>–<lpage>57</lpage> <page-range>e1</page-range>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>[26]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Toledo JB"><surname>Toledo</surname> <given-names>JB</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vanderstichele H"><surname>Vanderstichele</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Figurski M"><surname>Figurski</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aisen PS"><surname>Aisen</surname> <given-names>PS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Petersen RC"><surname>Petersen</surname> <given-names>RC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weiner MW"><surname>Weiner</surname> <given-names>MW</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-27">Factors affecting Abeta plasma levels and their utility as biomarkers in ADNI</article-title>. <source hwp:id="source-26">Acta neuropathologica</source>. <year>2011</year>;<volume>122</volume>:<fpage>401</fpage>–<lpage>13</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1"><label>[27]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Roberts KF"><surname>Roberts</surname> <given-names>KF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Elbert DL"><surname>Elbert</surname> <given-names>DL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kasten TP"><surname>Kasten</surname> <given-names>TP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patterson BW"><surname>Patterson</surname> <given-names>BW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sigurdson WC"><surname>Sigurdson</surname> <given-names>WC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Connors RE"><surname>Connors</surname> <given-names>RE</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-28">Amyloid-beta efflux from the central nervous system into the plasma</article-title>. <source hwp:id="source-27">Annals of neurology</source>. <year>2014</year>;<volume>76</volume>:<fpage>837</fpage>–<lpage>44</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1"><label>[28]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Chouraki V"><surname>Chouraki</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="De Bruijn RF"><surname>De Bruijn</surname> <given-names>RF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chapuis J"><surname>Chapuis</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bis JC"><surname>Bis</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reitz C"><surname>Reitz</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schraen S"><surname>Schraen</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-29">A genome-wide association meta-analysis of plasma Abeta peptides concentrations in the elderly</article-title>. <source hwp:id="source-28">Molecular psychiatry</source>. <year>2014</year>;<volume>19</volume>:<fpage>1326</fpage>–<lpage>35</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1"><label>[29]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Figurski MJ"><surname>Figurski</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Waligorska T"><surname>Waligorska</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Toledo J"><surname>Toledo</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vanderstichele H"><surname>Vanderstichele</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Korecka M"><surname>Korecka</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee VM"><surname>Lee</surname> <given-names>VM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-30">Improved protocol for measurement of plasma beta-amyloid in longitudinal evaluation of Alzheimer’s Disease Neuroimaging Initiative study patients</article-title>. <source hwp:id="source-29">Alzheimer’s &amp; dementia: the journal of the Alzheimer’s Association</source>. <year>2012</year>;<volume>8</volume>:<fpage>250</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30"><label>[30]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Ibrahim-Verbaas CA"><surname>Ibrahim-Verbaas</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zorkoltseva IV"><surname>Zorkoltseva</surname> <given-names>IV</given-names></string-name>, <string-name name-style="western" hwp:sortable="Amin N"><surname>Amin</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schuur M"><surname>Schuur</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Coppus AM"><surname>Coppus</surname> <given-names>AM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Isaacs A"><surname>Isaacs</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-31">Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Abeta-40 levels to presenilin 2</article-title>. <source hwp:id="source-30">Human genetics</source>. <year>2012</year>;<volume>131</volume>:<fpage>1869</fpage>–<lpage>76</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1"><label>[31]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Reitz C"><surname>Reitz</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cheng R"><surname>Cheng</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schupf N"><surname>Schupf</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee JH"><surname>Lee</surname> <given-names>JH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mehta PD"><surname>Mehta</surname> <given-names>PD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rogaeva E"><surname>Rogaeva</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-32">Association between variants in IDE-KIF11-HHEX and plasma amyloid beta levels</article-title>. <source hwp:id="source-31">Neurobiology of aging</source>. <year>2012</year>;<volume>33</volume>:<fpage>199</fpage> <page-range>e13–7</page-range>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1"><label>[32]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Winkler TW"><surname>Winkler</surname> <given-names>TW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Day FR"><surname>Day</surname> <given-names>FR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Croteau-Chonka DC"><surname>Croteau-Chonka</surname> <given-names>DC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wood AR"><surname>Wood</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Locke AE"><surname>Locke</surname> <given-names>AE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Magi R"><surname>Magi</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-33">Quality control and conduct of genome-wide association meta-analyses</article-title>. <source hwp:id="source-32">Nature protocols</source>. <year>2014</year>;<volume>9</volume>:<fpage>1192</fpage>–<lpage>212</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>[33]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Willer CJ"><surname>Willer</surname> <given-names>CJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li Y"><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Abecasis GR"><surname>Abecasis</surname> <given-names>GR</given-names></string-name>. <article-title hwp:id="article-title-34">METAL: fast and efficient meta-analysis of genomewide association scans</article-title>. <source hwp:id="source-33">Bioinformatics</source>. <year>2010</year>;<volume>26</volume>:<fpage>2190</fpage>–<lpage>1</lpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1 xref-ref-34-2"><label>[34]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="de Leeuw CA"><surname>de Leeuw</surname> <given-names>CA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mooij JM"><surname>Mooij</surname> <given-names>JM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Heskes T"><surname>Heskes</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Posthuma D"><surname>Posthuma</surname> <given-names>D</given-names></string-name>. <article-title hwp:id="article-title-35">MAGMA: generalized gene-set analysis of GWAS data</article-title>. <source hwp:id="source-34">PLoS computational biology</source>. <year>2015</year>;<volume>11</volume>:<fpage>e1004219</fpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>[35]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Becker JA"><surname>Becker</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hedden T"><surname>Hedden</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Carmasin J"><surname>Carmasin</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maye J"><surname>Maye</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rentz DM"><surname>Rentz</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Putcha D"><surname>Putcha</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-36">Amyloid-beta associated cortical thinning in clinically normal elderly</article-title>. <source hwp:id="source-35">Ann Neurol</source>. <year>2011</year>;<volume>69</volume>:<fpage>1032</fpage>–<lpage>42</lpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1"><label>[36]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Splansky GL"><surname>Splansky</surname> <given-names>GL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Corey D"><surname>Corey</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang Q"><surname>Yang</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="Atwood LD"><surname>Atwood</surname> <given-names>LD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cupples LA"><surname>Cupples</surname> <given-names>LA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Benjamin EJ"><surname>Benjamin</surname> <given-names>EJ</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-37">The Third Generation Cohort of the National Heart, Lung, and Blood Institute’s Framingham Heart Study: design, recruitment, and initial examination</article-title>. <source hwp:id="source-36">American journal of epidemiology</source>. <year>2007</year>;<volume>165</volume>:<fpage>1328</fpage>–<lpage>35</lpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1 xref-ref-37-2 xref-ref-37-3 xref-ref-37-4"><label>[37]</label><citation publication-type="other" citation-type="journal" ref:id="194266v4.37" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="de Rojas I"><surname>de Rojas</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Moreno-Grau S"><surname>Moreno-Grau</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tesi N B. G-B"><surname>Tesi</surname> <given-names>N B. G-B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Andrade V"><surname>Andrade</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jansen I"><surname>Jansen</surname> <given-names>I</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-38">Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores</article-title>. <source hwp:id="source-37">medRxiv</source>. <year>2019</year>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>[38]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Yamazaki Y"><surname>Yamazaki</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao N"><surname>Zhao</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caulfield TR"><surname>Caulfield</surname> <given-names>TR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu CC"><surname>Liu</surname> <given-names>CC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bu G"><surname>Bu</surname> <given-names>G</given-names></string-name>. <article-title hwp:id="article-title-39">Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies</article-title>. <source hwp:id="source-38">Nature reviews Neurology</source>. <year>2019</year>;<volume>15</volume>:<fpage>501</fpage>–<lpage>18</lpage>.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1"><label>[39]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Grothe MJ"><surname>Grothe</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Villeneuve S"><surname>Villeneuve</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dyrba M"><surname>Dyrba</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bartres-Faz D"><surname>Bartres-Faz</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wirth M"><surname>Wirth</surname> <given-names>M</given-names></string-name>, <collab hwp:id="collab-2">Alzheimer’s Disease Neuroimaging I</collab>. <article-title hwp:id="article-title-40">Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load</article-title>. <source hwp:id="source-39">Neurology</source>. <year>2017</year>;<volume>88</volume>:<fpage>569</fpage>–<lpage>76</lpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1"><label>[40]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Zhao N"><surname>Zhao</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu CC"><surname>Liu</surname> <given-names>CC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qiao W"><surname>Qiao</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bu G"><surname>Bu</surname> <given-names>G</given-names></string-name>. <article-title hwp:id="article-title-41">Apolipoprotein E, Receptors, and Modulation of Alzheimer’s Disease</article-title>. <source hwp:id="source-40">Biological psychiatry</source>. <year>2018</year>;<volume>83</volume>:<fpage>347</fpage>–<lpage>57</lpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>[41]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><string-name name-style="western" hwp:sortable="Miller KK"><surname>Miller</surname> <given-names>KK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hoffer A"><surname>Hoffer</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Svoboda KR"><surname>Svoboda</surname> <given-names>KR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lupica CR"><surname>Lupica</surname> <given-names>CR</given-names></string-name>. <article-title hwp:id="article-title-42">Cholecystokinin increases GABA release by inhibiting a resting K+ conductance in hippocampal interneurons</article-title>. <source hwp:id="source-41">The Journal of neuroscience: the official journal of the Society for Neuroscience</source>. <year>1997</year>;<volume>17</volume>:<fpage>4994</fpage>–<lpage>5003</lpage>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>[42]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Li QS"><surname>Li</surname> <given-names>QS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Parrado AR"><surname>Parrado</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Samtani MN"><surname>Samtani</surname> <given-names>MN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Narayan VA"><surname>Narayan</surname> <given-names>VA</given-names></string-name>, <collab hwp:id="collab-3">Alzheimer’s Disease Neuroimaging I</collab>. <article-title hwp:id="article-title-43">Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Abeta1-42 Level</article-title>. <source hwp:id="source-42">PloS one</source>. <year>2015</year>;<volume>10</volume>:<fpage>e0134000</fpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1"><label>[43]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Hnisz D"><surname>Hnisz</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Abraham BJ"><surname>Abraham</surname> <given-names>BJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee TI"><surname>Lee</surname> <given-names>TI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lau A"><surname>Lau</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Saint-Andre V"><surname>Saint-Andre</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sigova AA"><surname>Sigova</surname> <given-names>AA</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-44">Super-enhancers in the control of cell identity and disease</article-title>. <source hwp:id="source-43">Cell</source>. <year>2013</year>;<volume>155</volume>:<fpage>934</fpage>–<lpage>47</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1"><label>[44]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Hampel H"><surname>Hampel</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="O’Bryant SE"><surname>O’Bryant</surname> <given-names>SE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Molinuevo JL"><surname>Molinuevo</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zetterberg H"><surname>Zetterberg</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Masters CL"><surname>Masters</surname> <given-names>CL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lista S"><surname>Lista</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-45">Bloodbased biomarkers for Alzheimer disease: mapping the road to the clinic</article-title>. <source hwp:id="source-44">Nature reviews Neurology</source>. <year>2018</year>;<volume>14</volume>:<fpage>639</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1"><label>[45]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Olsson B"><surname>Olsson</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lautner R"><surname>Lautner</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Andreasson U"><surname>Andreasson</surname> <given-names>U</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ohrfelt A"><surname>Ohrfelt</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Portelius E"><surname>Portelius</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bjerke M"><surname>Bjerke</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-46">CSF and blood biomarkers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis</article-title>. <source hwp:id="source-45">The Lancet Neurology</source>. <year>2016</year>;<volume>15</volume>:<fpage>673</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>[46]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Sakai K"><surname>Sakai</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Senda T"><surname>Senda</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hata R"><surname>Hata</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kuroda M"><surname>Kuroda</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hasegawa M"><surname>Hasegawa</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kato M"><surname>Kato</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-47">Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer’s Disease by Removal of Blood Amyloid</article-title>. <source hwp:id="source-46">Journal of Alzheimer’s disease: JAD</source>. <year>2016</year>;<volume>51</volume>:<fpage>997</fpage>–<lpage>1002</lpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>[47]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Jin WS"><surname>Jin</surname> <given-names>WS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shen LL"><surname>Shen</surname> <given-names>LL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bu XL"><surname>Bu</surname> <given-names>XL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang WW"><surname>Zhang</surname> <given-names>WW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen SH"><surname>Chen</surname> <given-names>SH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huang ZL"><surname>Huang</surname> <given-names>ZL</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-48">Peritoneal dialysis reduces amyloid-beta plasma levels in humans and attenuates Alzheimer-associated phenotypes in an APP/PS1 mouse model</article-title>. <source hwp:id="source-47">Acta neuropathologica</source>. <year>2017</year>;<volume>134</volume>:<fpage>207</fpage>–<lpage>20</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><label>[48]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Mullard A"><surname>Mullard</surname> <given-names>A</given-names></string-name>. <article-title hwp:id="article-title-49">BACE inhibitor bust in Alzheimer trial</article-title>. <source hwp:id="source-48">Nature reviews Drug discovery</source>. <year>2017</year>;<volume>16</volume>:<fpage>155</fpage>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>[49]</label><citation publication-type="journal" citation-type="journal" ref:id="194266v4.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Fullwood NJ"><surname>Fullwood</surname> <given-names>NJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hayashi Y"><surname>Hayashi</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Allsop D"><surname>Allsop</surname> <given-names>D</given-names></string-name>. <article-title hwp:id="article-title-50">Plasma amyloid-beta concentrations in Alzheimer’s disease: an alternative hypothesis</article-title>. <source hwp:id="source-49">The Lancet Neurology</source>. <year>2006</year>;<volume>5</volume>:<fpage>1000</fpage>–<lpage>1</lpage>; author reply 2-3.</citation></ref></ref-list></back></article>
